Großimlinghaus I, Hauth I, Falkai P, Janssen B, Deister A, Meyer-Lindenberg A, Roth-Sackenheim C, Schneider F, Wobrock T, Zeidler R, Gaebel W
LVR-Institut für Versorgungsforschung, WHO Collaborating Center for Quality Assurance and Empowerment in Mental Health, Medizinische Fakultät, LVR-Klinikum Düsseldorf, Heinrich-Heine-Universität, Bergische Landstraße 2, 40629, Düsseldorf, Deutschland.
Zentrum für Neurologie, Psychiatrie, Psychotherapie und Psychosomatik, Alexianer St. Joseph Krankenhaus Berlin-Weißensee, Berlin, Deutschland.
Nervenarzt. 2017 Jul;88(7):779-786. doi: 10.1007/s00115-017-0347-6.
In Germany, several quality indicators have been proposed for the measurement of quality of mental healthcare. Some of these quality indicators have been tested in feasibility studies. The German Association for Psychiatry and Psychotherapy (DGPPN) established the "Task Force Quality Indicators (QI)" that, based on previous experience in the development and pilot testing of indicators, considered the further development and practical realization of QI for schizophrenia.
The aim was to select a set of QI for schizophrenia that can also be applied to other diagnoses or used in generic measurements. Another goal was to focus on high feasibility of indicators.
In a multistage selection process, the DGPPN Task Force selected QI that focus on essential quality aspects from an inventory of 161 existing QI developed by national and international research groups. Indicators were adapted in consultation with the "trialogic forum" of the DGPPN.
The DGPPN proposes the following ten indicators for quality measurement in mental healthcare for schizophrenia: QI1 Long-term treatment/Monitoring of side effects, QI2 Seclusion and restraint, QI3 Number of suicides, QI4 Psychoeducational-oriented intervention for significant others, QI5 Timely beginning of outpatient treatment after discharge from inpatient treatment, QI6 Aggression management - inpatient treatment, QI7 Diagnostic procedures/Physical examination, QI8 Antipsychotic polypharmacy, QI9 Rehabilitation/Vocational rehabilitation, QI10 Diagnostic procedures/Psychosocial functioning.
Most of our proposed QI have to be measured by means of additional data documentation. Based on prior experience in the pilot testing of QI, the DGPPN estimates that the additional efforts in data documentation would be manageable, but have to be refinanced. The indicators will be tested in feasibility studies in different mental healthcare hospitals in Germany.
在德国，已提出多项用于衡量精神卫生保健质量的质量指标。其中一些质量指标已在可行性研究中进行了测试。德国精神病学和心理治疗协会（DGPPN）成立了“质量指标工作组（QI）”，该工作组基于先前在指标开发和试点测试方面的经验，考虑对精神分裂症质量指标进行进一步开发和实际应用。
目的是选择一组可用于精神分裂症的质量指标，这些指标也可应用于其他诊断或用于一般测量。另一个目标是关注指标的高可行性。
在一个多阶段选择过程中，DGPPN工作组从国家和国际研究小组制定的161项现有质量指标清单中选择了关注基本质量方面的质量指标。指标经与DGPPN的“三方论坛”协商后进行了调整。
DGPPN提出了以下十项用于精神分裂症精神卫生保健质量测量的指标：QI1长期治疗/副作用监测，QI2隔离和约束，QI3自杀人数，QI4针对重要他人的心理教育导向干预，QI5住院治疗出院后及时开始门诊治疗，QI6攻击管理 - 住院治疗，QI7诊断程序/体格检查，QI8抗精神病药物联合使用，QI9康复/职业康复，QI10诊断程序/心理社会功能。
我们提出的大多数质量指标必须通过额外的数据记录来测量。基于先前质量指标试点测试的经验，DGPPN估计数据记录方面的额外工作是可控的，但必须重新筹集资金。这些指标将在德国不同的精神卫生保健医院进行可行性研究测试。
